The study examines results from more than 35 publishes studies, including a 10-year follow-up study. The study found that Stretta is an effective therapy that fills the gap in GERD treatment between medications and surgery. The procedure results in:
• Effective symptom control in patients who were previously PPI dependent or exhibited poor response to PPIs
• Improved acid sensitivity and decreased tissue compliance
Stretta is also the least expensive alternative to medical therapy, according to the study.
More Articles on Gastroenterology:
8 ASC Industry Gastroenterologist Leaders to Know
Is CRC Colonoscopy Cost-Effectiveness Sustainable?
The Role of Informed Patient Choice in CRC Screening Adherence
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
